Temporal cross talk between endoplasmic reticulum and mitochondria regulates oxidative stress and mediates microparticle-induced endothelial dysfunction
Date
2017-01-01Author
Safiedeen, ZainabRodríguez-Gómez, Isabel
Vergori, Luisa
Soleti, Raffaella
Vaithilingam, Dayannath
Douma, Imene
Agouni, Abdelali
Leiber, Denis
Dubois, Séverine
Simard, Gilles
Zibara, Kazem
Andriantsitohaina, Ramaroson
Martínez, M. Carmen
...show more authors ...show less authors
Metadata
Show full item recordAbstract
Aims: Circulating microparticles (MPs) from metabolic syndrome patients
and those generated from apoptotic T-cells induce endothelial
dysfunction; however, the molecular and cellular mechanism(s) underlying
in the effects of MPs remain to be elucidated. Results: Here, we show that
both types of MPs increased expression of endoplasmic reticulum (ER)
stress markers XBP-1, p-eIF2alpha and CHOP and nuclear translocation of
ATF6 on human aortic endothelial cells. MPs decreased in vitro nitric
oxide release by human aortic endothelial cells, whereas in vivo MP
injection into mice impaired the endothelium-dependent relaxation
induced by acetylcholine. These effects were prevented when ER stress
was inhibited suggesting that ER stress is implicated in the endothelial
effects induced by MPs. MPs affected mitochondrial function and evoked
sequential increase of cytosolic and mitochondrial reactive oxygen
species (ROS). Pharmacological inhibition of ER stress and silencing of
neutral sphingomyelinase with siRNA abrogated all MP-mediated effects.
Neutralization of Fas-Ligand carried by MPs abolished effects induced by
both MP types, whereas neutralization of low density lipoprotein-receptor
on endothelial cells prevented T-lymphocyte MP-mediated effects.
Innovation and Conclusion: Collectively, endothelial dysfunction triggered
by MPs involves temporal cross-talk between ER and mitochondria with
respect to spatial regulation of ROS via the neutral sphingomyelinase and
interaction of MPs with Fas and/or low density lipoprotein-receptor. These
results provide a novel molecular insight into the manner MPs mediate
vascular dysfunction and allow identification of potential therapeutic
targets to treat vascular complications associated with metabolic
syndrome.
Collections
- Pharmacy Research [1320 items ]